1Wang, C, Harris, WS, Chung, M, et al. (2006) n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84, 5–17.
2Burr, ML, Fehily, AM, Gilbert, JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 334, 757–761.
3Marchioli, R, Barzi, F, Bomba, E, et al. (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 1897–1903.
4Yokoyama, M, Origasa, H, Matsuzaki, M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 369, 1090–1098.
5Hu, FB, Bronner, L, Willett, WC, et al. (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815–1821.
6Sun, Q, Ma, J, Campos, H, et al. (2008) Blood concentrations of individual long-chain n-3 fatty acids and risk of non-fatal myocardial infarction. Am J Clin Nutr 88, 216–223.
7Ascherio, A, Rimm, EB, Stampfer, MJ, et al. (1995) Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 332, 977–982.
8Morris, MC, Manson, JE, Rosner, B, et al. (1995) Fish consumption and cardiovascular disease in the Physicians' Health Study: a prospective study. Am J Epidemiol 142, 166–175.
9Chambless, LE, Folsom, AR, Sharrett, AR, et al. (2003) Coronary heart disease risk prediction in the atherosclerosis risk in communities (ARIC) study. J Clin Epidemiol 56, 880–890.
10Wilson, PW, D'Agostino, RB, Levy, D, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847.
11Harris, WS & Von Schacky, C (2004) The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med 39, 212–220.
12Clifton, PM, Keogh, JB & Noakes, M (2004) Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 134, 874–879.
13Harris, WS, Poston, WC & Haddock, CK (2007) Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193, 1–10.
14Harris, WS, Park, Y & Isley, WL (2003) Cardiovascular disease and long-chain omega-3 fatty acids. Curr Opin Lipidol 14, 9–14.
15Mozaffarian, D, Pischon, T, Hankinson, SE, et al. (2004) Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 79, 606–612.
16Mori, TA & Woodman, RJ (2006) The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9, 95–104.
17Wilson, PW, D'Agostino, RB, Levy, D, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847.
18Dewailly, E, Blanchet, C, Gingras, S, et al. (2001) Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. Am J Clin Nutr 74, 603–611.
19Block, RC, Harris, WS, Reid, KJ, et al. (2008) EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 197, 821–828.
20Harris, WS, Poston, WC & Haddock, CK (2007) Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193, 1–10.
21Albert, CM, Campos, H, Stampfer, MJ, et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346, 1113–1118.
22Mozaffarian, D, Katan, MB, Ascherio, A, et al. (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354, 1601–1613.
23Sun, Q, Ma, Jing, Campos, H, et al. (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115, 1858–1865.
24Block, RC, Harris, WS, Reid, KJ, et al. (2008) Omega-6 and trans fatty acids in blood cell membranes: a risk factor for acute coronary syndromes? Am Heart J 156, 1117–1123.
25Park, Y & Harris, WS (2002) EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids 37, 941–946.
26Thies, F, Garry, JM, Yaqoob, P, et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 361, 477–485.
27Wada, M, DeLong, CJ, Hong, YH, et al. (2007) Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 282, 22254–22266.
28Pedersen, JI, Ringstad, J, Almendingen, K, et al. (2000) Adipose tissue fatty acids and risk of myocardial infarction– a case–control study. Eur J Clin Nutr 54, 618–625.
29Kark, JD, Manor, O, Goldman, S, et al. (1995) Stability of red blood cell membrane fatty acid composition after acute myocardial infarction. J Clin Epidemiol 48, 889–895.
30De Caterina, R, Madonna, R, Bertolotto, A, et al. (2007) n-3 Fatty acids in the treatment of diabetic patients: biological rationale and clinical data. Diabetes Care 30, 1012–1026.
31Mensink, RP, Zock, PL, Kester, AD, et al. (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.